Community Health Stock Hit By Weak Patient Volume

CYH short sellers may have hit the exits too soon

Aug 2, 2017 at 9:11 AM
facebook twitter linkedin

Analysts are weighing in on travel technology provider Sabre Corp (NASDAQ:SABR), hospital stock Community Health Systems (NYSE:CYH), and oilfield services provider Baker Hughes (NYSE:BHGE). Here's a quick roundup of today's bearish brokerage notes on shares of SABR, CYH, and BHGE.

Analysts Lower Expectations on SABR Stock After Earnings Meltdown

After the stock tanked to two-year lows yesterday after earnings, analysts are weighing in on Sabre. Specifically, price-target cuts have come through from Cowen ($23), Morgan Stanley ($23), and Mizuho ($25) -- though all three represent a premium to SABR's close yesterday at $19.81. Interestingly, analysts have stayed bullish on Sabre stock, even though it's down more than 32% year-over-year. That is, six of eight brokerage firms maintain "strong buy" recommendations. 

Weak Patient Volume Weighs on CYH Shares

A disappointing full-year outlook could weigh on Community Health Systems stock today. The company is lowering its forecast for the year amid weaker patient volumes, prompting a round of negative attention from analysts. Oppenheimer, Cantor Fitzgerald, and Mizuho all lowered their price targets, with the latter setting the lowest mark of $7. 

CYH stock settled Tuesday at $6.88, down 45% over the past year. Still, short interest has been falling sharply since peaking late September. In the last two reporting periods, short interest on Community Health Systems dropped 18.4%. 

Analysts Trim Outlook as Baker Hughes Continues Descent

HSBC this morning lowered its price target on Baker Hughes stock to $46 from $48, though this stands near the shares' 52-week high, and well above last night's close of $35.70. BHGE has carved out a series of lower highs since mid-December, giving back 21% year-to-date. Considering this, the shares could be due for more bearish analyst attention, given the fact that their average 12-month price target still stands at $52.99 -- a 48% premium to current levels. 

Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!